Device Trial Radar · NCT02758548
Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects
Last checked: Nov 19, 2026Latest source record: Nov 15, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
193
Actual
Start
Mar 2016
Primary completion
May 2016
Study completion May 2016
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 2, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 6 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the accuracy of the Novel point of care test (POCT) total IgE assay in atopic patients. 120 patients with atopic conditions and approximately 40 healthy subjects will be enrolled. Fingerstick capillary blood samples will be collected and tested in the POCT device. Venous samples will be collected and sent to a reference laboratory for measurement of serum total IgE using the reference immunoassay method.
Conditions
- Atopic Asthma
Interventions
Blood sampleProcedure
Fingerprick and venous
POCT deviceDevice
Investigational device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total IgE concentrationTime frame: Day 0 or Day 1 (Visit 2: Blood sampling)
Locations
12 sites in 5 countries. Site status is shown where the registry gives one.
Novartis Investigative Site
Hamburg, Germany
Novartis Investigative Site
Lübeck, Germany
Novartis Investigative Site
Padova, PD, Italy
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.